Clinical Trials in New York

Showing 4901-4920 of 22,668 trials

Enhancing Engagement of Partners in Research

NCT07166913

The purpose of this study is to examine the implementation and effectiveness of a bundle of engagement strategies for pediatric patient centered outcomes research (PCOR) studies. The study aims to examine the effectiveness of a "bundle" of enhanced engagement strategies on improved stakeholder engagement and study protocol indicators (including improved language access, meeting recruitment/retention goals) compared to standard practice.

Stakeholder Engagement

NYU Langone Health480 participantsStarted Sep 2025

New York, New York, United States

RECRUITINGNA< 1 mile

ARIADNE Clinical Trial

NCT06747091

A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.

Persistent Atrial Fibrillation

Stavros E Mountantonakis60 participantsStarted Mar 2025

Manhasset, New York, United States • New Hyde Park, New York, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

NCT05107128

The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance and functioning in participants with HD.

Huntington's Disease

Supernus Pharmaceuticals, Inc.189 participantsStarted Jan 2022

Little Rock, Arkansas, United States • La Jolla, California, United States • Los Angeles, California, United States +46 more locations

Enhancing Engagement of Partners in Research

ARIADNE Clinical Trial

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Find Trials by Condition in New York

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

Transcranial Ultrasound Via Sonolucent Cranioplasty

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Engaging Black Youth in Depression and Suicide Prevention Treatment Within Urban Schools

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Study of Anti-Malarials in Incomplete Lupus Erythematosus

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Veterans Response to Dosage in Chiropractic Therapy

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Promising ROd-cone DYstrophy Gene therapY

Omnipod 5 System Compared to Pump Therapy

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis